BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dalhoff K, Dancey J, Astrup L, Skovsgaard T, Hamberg KJ, Lofts FJ, Rosmorduc O, Erlinger S, Bach Hansen J, Steward WP. A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma. Br J Cancer. 2003;89:252-257. [PMID: 12865912 DOI: 10.1038/sj.bjc.6601104] [Cited by in Crossref: 121] [Cited by in F6Publishing: 102] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Feldman D, Malloy PJ, Krishnan AV, Balint E. Vitamin D: Biology, Action, and Clinical Implications. Osteoporosis. Elsevier; 2008. pp. 317-82. [DOI: 10.1016/b978-012370544-0.50015-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
2 Llovet JM, Montal R, Sia D, Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 2018;15:599-616. [PMID: 30061739 DOI: 10.1038/s41571-018-0073-4] [Cited by in Crossref: 482] [Cited by in F6Publishing: 494] [Article Influence: 160.7] [Reference Citation Analysis]
3 Segersten U, Holm PK, Binderup L, Akerström G, Hellman P, Westin G. Vitamin D3 polyunsaturated side-chain analogues (EB1089, GS1590) and the 20-epi-vitamin D3 analogue CB1393 suppress parathyroid hormone secretion and mRNA level in bovine parathyroid cells. J Steroid Biochem Mol Biol 2004;88:289-94. [PMID: 15120422 DOI: 10.1016/j.jsbmb.2003.12.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
4 Matsumoto Y, Kittaka A, Chen TC. 19-Norvitamin D analogs for breast cancer therapy. Can J Physiol Pharmacol 2015;93:333-48. [PMID: 25918960 DOI: 10.1139/cjpp-2014-0452] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
5 Luong Kv, Nguyen LT. The beneficial role of vitamin D and its analogs in cancer treatment and prevention. Crit Rev Oncol Hematol 2010;73:192-201. [PMID: 19446468 DOI: 10.1016/j.critrevonc.2009.04.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
6 Kissmeyer AM, Nielsen JL, Binderup L. The tissue-specific distribution of 3H-seocalcitol (EB 1089) and 3H-calcitriol in rats. J Steroid Biochem Mol Biol 2004;89-90:43-7. [PMID: 15225745 DOI: 10.1016/j.jsbmb.2004.03.049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Díaz L, Díaz-Muñoz M, García-Gaytán AC, Méndez I. Mechanistic Effects of Calcitriol in Cancer Biology. Nutrients 2015;7:5020-50. [PMID: 26102214 DOI: 10.3390/nu7065020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 7.6] [Reference Citation Analysis]
8 Lu Y, Kou Y, Gao Y, Yang P, Liu S, Zhang F, Li M. Eldecalcitol inhibits the progression of oral cancer by suppressing the expression of GPx-1. Oral Dis 2021. [PMID: 34431176 DOI: 10.1111/odi.14010] [Reference Citation Analysis]
9 Chen EQ, Shi Y, Tang H. New insight of vitamin D in chronic liver diseases. Hepatobiliary Pancreat Dis Int 2014;13:580-5. [PMID: 25475859 DOI: 10.1016/s1499-3872(14)60295-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
10 Hu N, Zhang H. CYP24A1 depletion facilitates the antitumor effect of vitamin D3 on thyroid cancer cells. Exp Ther Med 2018;16:2821-30. [PMID: 30233662 DOI: 10.3892/etm.2018.6536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Wietrzyk J, Nevozhay D, Milczarek M, Filip B, Kutner A. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model. Cancer Chemother Pharmacol 2008;62:787-97. [PMID: 18188568 DOI: 10.1007/s00280-007-0666-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
12 Campbell MJ, Trump DL. Vitamin D Receptor Signaling and Cancer. Endocrinol Metab Clin North Am 2017;46:1009-38. [PMID: 29080633 DOI: 10.1016/j.ecl.2017.07.007] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 6.8] [Reference Citation Analysis]
13 Harris DM, Go VLW. Vitamin D and Colon Carcinogenesis. The Journal of Nutrition 2004;134:3463S-71S. [DOI: 10.1093/jn/134.12.3463s] [Cited by in Crossref: 75] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
14 Lange CM, Miki D, Ochi H, Nischalke HD, Bojunga J, Bibert S, Morikawa K, Gouttenoire J, Cerny A, Dufour JF. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PLoS One. 2013;8:e64053. [PMID: 23734184 DOI: 10.1371/journal.pone.0064053] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
15 Leyssens C, Verlinden L, Verstuyf A. The future of vitamin D analogs. Front Physiol. 2014;5:122. [PMID: 24772087 DOI: 10.3389/fphys.2014.00122] [Cited by in Crossref: 84] [Cited by in F6Publishing: 71] [Article Influence: 10.5] [Reference Citation Analysis]
16 Bouillon R, Eelen G, Verlinden L, Mathieu C, Carmeliet G, Verstuyf A. Vitamin D and cancer. The Journal of Steroid Biochemistry and Molecular Biology 2006;102:156-62. [DOI: 10.1016/j.jsbmb.2006.09.014] [Cited by in Crossref: 128] [Cited by in F6Publishing: 109] [Article Influence: 8.0] [Reference Citation Analysis]
17 Perry JF, Strasser SI, George J, Farrell GC, Mccaughan GW. Pharmacotherapy of hepatocellular carcinoma. Expert Opinion on Pharmacotherapy 2005;4:2175-85. [DOI: 10.1517/14656566.4.12.2175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
18 Grabacka M, Placha W, Urbanska K, Laidler P, Płonka PM, Reiss K. PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91. Pigment Cell Melanoma Res 2008;21:388-96. [PMID: 18444964 DOI: 10.1111/j.1755-148X.2008.00460.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
19 Zhu J, Yu K, de Mello RA. Hepatocellular Carcinoma. In: de Mello RA, Tavares Á, Mountzios G, editors. International Manual of Oncology Practice. Cham: Springer International Publishing; 2015. pp. 327-42. [DOI: 10.1007/978-3-319-21683-6_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
20 Tanaka S, Arii S. Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma. Int J Clin Oncol. 2006;11:82-89. [PMID: 16622743 DOI: 10.1007/s10147-006-0566-5] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
21 Wang W, Zhao CH, Zhang N, Wang J. Vitamin D analog EB1089 induces apoptosis in a subpopulation of SGC-7901 gastric cancer cells through a mitochondrial-dependent apoptotic pathway. Nutr Cancer. 2013;65:1067-1075. [PMID: 24099173 DOI: 10.1080/01635581.2013.811273] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
22 Majumdar A, Curley SA, Wu X, Brown P, Hwang JP, Shetty K, Yao ZX, He AR, Li S, Katz L. Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2012;9:530-538. [PMID: 22710573 DOI: 10.1038/nrgastro.2012.114] [Cited by in Crossref: 90] [Cited by in F6Publishing: 92] [Article Influence: 9.0] [Reference Citation Analysis]
23 Mutchie TR, Yu OB, Di Milo ES, Arnold LA. Alternative binding sites at the vitamin D receptor and their ligands. Mol Cell Endocrinol 2019;485:1-8. [PMID: 30654005 DOI: 10.1016/j.mce.2019.01.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
24 Seoane S, Ben I, Centeno V, Perez-fernandez R. Cellular Expression Levels of the Vitamin D Receptor Are Critical to Its Transcriptional Regulation by the Pituitary Transcription Factor Pit-1. Molecular Endocrinology 2007;21:1513-25. [DOI: 10.1210/me.2006-0554] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
25 Adelani IB, Rotimi OA, Maduagwu EN, Rotimi SO. Vitamin D: Possible Therapeutic Roles in Hepatocellular Carcinoma. Front Oncol 2021;11:642653. [PMID: 34113565 DOI: 10.3389/fonc.2021.642653] [Reference Citation Analysis]
26 Li Z, Jia Z, Gao Y, Xie D, Wei D, Cui J, Mishra L, Huang S, Zhang Y, Xie K. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness. Clin Cancer Res 2015;21:844-53. [PMID: 25501129 DOI: 10.1158/1078-0432.CCR-14-2437] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
27 Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C, Demay M. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29:726-776. [PMID: 18694980 DOI: 10.1210/er.2008-0004] [Cited by in Crossref: 1020] [Cited by in F6Publishing: 902] [Article Influence: 72.9] [Reference Citation Analysis]
28 Iyer P, Diamond FB. Shedding Light on Hypovitaminosis D and Rickets. Advances in Pediatrics 2007;54:115-33. [DOI: 10.1016/j.yapd.2007.03.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Jones G. Vitamin D Analogs. Rheumatic Disease Clinics of North America 2012;38:207-32. [DOI: 10.1016/j.rdc.2012.03.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Kittaka A, Yoshida A, Chiang KC, Takano M, Sawada D, Sakaki T, Chen TC. Potent 19-norvitamin D analogs for prostate and liver cancer therapy. Future Med Chem 2012;4:2049-65. [PMID: 23157238 DOI: 10.4155/fmc.12.130] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
31 Luong QT, Koeffler HP. Vitamin D compounds in leukemia. The Journal of Steroid Biochemistry and Molecular Biology 2005;97:195-202. [DOI: 10.1016/j.jsbmb.2005.06.017] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.3] [Reference Citation Analysis]
32 Woloszynska-Read A, Johnson CS, Trump DL. Vitamin D and cancer: clinical aspects. Best Pract Res Clin Endocrinol Metab 2011;25:605-15. [PMID: 21872802 DOI: 10.1016/j.beem.2011.06.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
33 Glen H, Cassidy J. Vitamin D (and its analogs) in the treatment and prevention of cancer. Expert Rev Anticancer Ther 2006;6:305-8. [PMID: 16503846 DOI: 10.1586/14737140.6.3.305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
34 Macejová D, Ondková S, Jakubíková L, Mlynarčíková A, Scsuková S, Liška J, Brtko J. MNU-induced mammary gland carcinogenesis: chemopreventive and therapeutic effects of vitamin D and Seocalcitol on selected regulatory vitamin D receptor pathways. Toxicol Lett 2011;207:60-72. [PMID: 21843606 DOI: 10.1016/j.toxlet.2011.07.029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
35 Tykwinska K, Lauster R, Knaus P, Rosowski M. Growth and differentiation factor 3 induces expression of genes related to differentiation in a model of cancer stem cells and protects them from retinoic acid-induced apoptosis. PLoS One 2013;8:e70612. [PMID: 23950971 DOI: 10.1371/journal.pone.0070612] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
36 Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of vitamin D in cancer prevention and treatment. Rheum Dis Clin North Am 2012;38:161-78. [PMID: 22525850 DOI: 10.1016/j.rdc.2012.03.014] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
37 Kwok RM, Torres DM, Harrison SA. Vitamin D and nonalcoholic fatty liver disease (NAFLD): Is it more than just an association?: Hepatology. Hepatology 2013;58:1166-74. [DOI: 10.1002/hep.26390] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
38 Wietrzyk J, Pełczyńska M, Madej J, Dzimira S, Kuśnierczyk H, Kutner A, Szelejewski W, Opolski A. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191). Steroids 2004;69:629-35. [PMID: 15465107 DOI: 10.1016/j.steroids.2004.05.015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
39 Jones G. Vitamin D and Analogues. Principles of Bone Biology. Elsevier; 2008. pp. 1777-99. [DOI: 10.1016/b978-0-12-373884-4.00087-2] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
40 Fernandez-Garcia NI, Palmer HG, Garcia M, Gonzalez-Martin A, del Rio M, Barettino D, Volpert O, Muñoz A, Jimenez B. 1alpha,25-Dihydroxyvitamin D3 regulates the expression of Id1 and Id2 genes and the angiogenic phenotype of human colon carcinoma cells. Oncogene 2005;24:6533-44. [PMID: 16007183 DOI: 10.1038/sj.onc.1208801] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 4.1] [Reference Citation Analysis]
41 Wu X, Hu W, Lu L, Zhao Y, Zhou Y, Xiao Z, Zhang L, Zhang H, Li X, Li W, Wang S, Cho CH, Shen J, Li M. Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment.Acta Pharm Sin B. 2019;9:203-219. [PMID: 30972274 DOI: 10.1016/j.apsb.2018.09.002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
42 Easty DJ, Farr CJ, Hennessy BT. New Roles for Vitamin D Superagonists: From COVID to Cancer. Front Endocrinol (Lausanne) 2021;12:644298. [PMID: 33868174 DOI: 10.3389/fendo.2021.644298] [Reference Citation Analysis]
43 Karami S, Brennan P, Rosenberg PS, Navratilova M, Mates D, Zaridze D, Janout V, Kollarova H, Bencko V, Matveev V, Szeszenia-Dabrowska N, Holcatova I, Yeager M, Chanock S, Menashe I, Rothman N, Chow WH, Boffetta P, Moore LE. Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk. PLoS One 2009;4:e7013. [PMID: 19753122 DOI: 10.1371/journal.pone.0007013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
44 Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development. 2005;132:3151-3161. [PMID: 15983400 DOI: 10.1242/dev.01907] [Cited by in Crossref: 932] [Cited by in F6Publishing: 901] [Article Influence: 54.8] [Reference Citation Analysis]
45 Chiang KC, Yeh CN, Chen MF, Chen TC. Hepatocellular carcinoma and vitamin D: a review. J Gastroenterol Hepatol. 2011;26:1597-1603. [PMID: 21880026 DOI: 10.1111/j.1440-1746.2011.06892.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
46 N'kontchou G, Mahamoudi A, Aout M, Ganne-carrié N, Grando V, Coderc E, Vicaut E, Trinchet JC, Sellier N, Beaugrand M, Seror O. Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009;50:1475-83. [DOI: 10.1002/hep.23181] [Cited by in Crossref: 284] [Cited by in F6Publishing: 268] [Article Influence: 21.8] [Reference Citation Analysis]
47 Trump DL, Deeb KK, Johnson CS. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy. Cancer J. 2010;16:1-9. [PMID: 20164683 DOI: 10.1097/ppo.0b013e3181c51ee6] [Cited by in Crossref: 115] [Cited by in F6Publishing: 53] [Article Influence: 9.6] [Reference Citation Analysis]
48 Peña C, García JM, Silva J, García V, Rodríguez R, Alonso I, Millán I, Salas C, de Herreros AG, Muñoz A, Bonilla F. E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet 2005;14:3361-70. [PMID: 16203744 DOI: 10.1093/hmg/ddi366] [Cited by in Crossref: 128] [Cited by in F6Publishing: 125] [Article Influence: 7.5] [Reference Citation Analysis]
49 Brozyna A, Zbytek B, Granese J, Carlson JA, Ross J, Slominski A. Mechanism of UV-related carcinogenesis and its contribution to nevi/melanoma. Expert Review of Dermatology 2014;2:451-69. [DOI: 10.1586/17469872.2.4.451] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 8.9] [Reference Citation Analysis]
50 Kaya T, Swamy N, Persons KS, Ray S, Mohr SC, Ray R. Covalent labeling of nuclear vitamin D receptor with affinity labeling reagents containing a cross-linking probe at three different positions of the parent ligand: structural and biochemical implications. Bioorg Chem 2009;37:57-63. [PMID: 19223058 DOI: 10.1016/j.bioorg.2009.01.001] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
51 Wu DB, Wang ML, Chen EQ, Tang H. New insights into the role of vitamin D in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol 2018;12:287-94. [PMID: 29140126 DOI: 10.1080/17474124.2018.1406307] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
52 Louka ML, Fawzy AM, Naiem AM, Elseknedy MF, Abdelhalim AE, Abdelghany MA. Vitamin D and K signaling pathways in hepatocellular carcinoma. Gene 2017;629:108-16. [PMID: 28764978 DOI: 10.1016/j.gene.2017.07.074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
53 Fu Z, Xu C, Shu Y, Xie Z, Lu C, Mo X. Serum 25-hydroxyvitamin D is associated with obesity and metabolic parameters in US children. Public Health Nutr 2020;23:1214-22. [PMID: 31120008 DOI: 10.1017/S1368980019001137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
54 Dimitroulopoulos D, Xinopoulos D, Tsamakidis K, Zisimopoulos A, Andriotis E, Panagiotakos D, Fotopoulou A, Chrysohoou C, Bazinis A, Daskalopoulou D, Paraskevas E. Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: Randomized placebo-controlled trial. World J Gastroenterol 2007; 13(23): 3164-3170 [PMID: 17589893 DOI: 10.3748/wjg.v13.i23.3164] [Cited by in CrossRef: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
55 Mostafa BE, Abdelmageed HM, El-begermy MM, Taha MS, Hamdy TA, Omran A, Lotfy N. Value of vitamin D assessment in patients with head and neck squamous cell cancer before treatment. Egypt J Otolaryngol 2016;32:279-86. [DOI: 10.4103/1012-5574.192550] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Elangovan H, Chahal S, Gunton JE. Vitamin D in liver disease: Current evidence and potential directions.Biochim Biophys Acta Mol Basis Dis. 2017;1863:907-916. [PMID: 28064017 DOI: 10.1016/j.bbadis.2017.01.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
57 Lambert JR, Young CD, Persons KS, Ray R. Mechanistic and pharmacodynamic studies of a 25-hydroxyvitamin D3 derivative in prostate cancer cells. Biochem Biophys Res Commun 2007;361:189-95. [PMID: 17658477 DOI: 10.1016/j.bbrc.2007.07.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
58 Hao M, Hou S, Xue L, Yuan H, Zhu L, Wang C, Wang B, Tang C, Zhang C. Further Developments of the Phenyl-Pyrrolyl Pentane Series of Nonsteroidal Vitamin D Receptor Modulators as Anticancer Agents. J Med Chem 2018;61:3059-75. [PMID: 29518319 DOI: 10.1021/acs.jmedchem.8b00106] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
59 Vaishya R, Vijay V, Agarwal AK, Jahangir J. Resurgence of vitamin D: Old wine in new bottle. J Clin Orthop Trauma 2015;6:173-83. [PMID: 26155053 DOI: 10.1016/j.jcot.2015.02.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
60 Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev 2016;96:365-408. [PMID: 26681795 DOI: 10.1152/physrev.00014.2015] [Cited by in Crossref: 654] [Cited by in F6Publishing: 557] [Article Influence: 109.0] [Reference Citation Analysis]
61 Hsu JW, Yasmin-Karim S, King MR, Wojciechowski JC, Mickelsen D, Blair ML, Ting HJ, Ma WL, Lee YF. Suppression of prostate cancer cell rolling and adhesion to endothelium by 1α,25-dihydroxyvitamin D3. Am J Pathol 2011;178:872-80. [PMID: 21281819 DOI: 10.1016/j.ajpath.2010.10.036] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
62 Lundqvist J, Hansen SK, Lykkesfeldt AE. Vitamin D analog EB1089 inhibits aromatase expression by dissociation of comodulator WSTF from the CYP19A1 promoter-a new regulatory pathway for aromatase. Biochim Biophys Acta 2013;1833:40-7. [PMID: 23085504 DOI: 10.1016/j.bbamcr.2012.10.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
63 Lương KVQ, Nguyễn LTH. Theoretical basis of a beneficial role for vitamin D in viral hepatitis. World J Gastroenterol 2012; 18(38): 5338-5350 [PMID: 23082050 DOI: 10.3748/wjg.v18.i38.5338] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
64 Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev. 2005;26:662-687. [PMID: 15798098 DOI: 10.1210/er.2004-0002] [Cited by in Crossref: 591] [Cited by in F6Publishing: 532] [Article Influence: 34.8] [Reference Citation Analysis]
65 Gupta D, Vashi PG, Trukova K, Lis CG, Lammersfeld CA. Prevalence of serum vitamin D deficiency and insufficiency in cancer: Review of the epidemiological literature. Exp Ther Med 2011;2:181-93. [PMID: 22977487 DOI: 10.3892/etm.2011.205] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
66 Zúñiga S, Firrincieli D, Housset C, Chignard N. Vitamin D and the vitamin D receptor in liver pathophysiology. Clin Res Hepatol Gastroenterol 2011;35:295-302. [PMID: 21440524 DOI: 10.1016/j.clinre.2011.02.003] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
67 Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010;9:941-955. [PMID: 21119732 DOI: 10.1038/nrd3318] [Cited by in Crossref: 288] [Cited by in F6Publishing: 250] [Article Influence: 26.2] [Reference Citation Analysis]
68 Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7:684-700. [PMID: 17721433 DOI: 10.1038/nrc2196] [Cited by in Crossref: 891] [Cited by in F6Publishing: 833] [Article Influence: 59.4] [Reference Citation Analysis]
69 Iyer N, Marathe SA, Chaudhuri D, Garai P, Chakravortty D. Immunomodulation using agonists and antagonists: potential clinical applications. Expert Opin Investig Drugs 2012;21:67-81. [PMID: 22149716 DOI: 10.1517/13543784.2012.642367] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Wang X, Harrison JS, Studzinski GP. BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents. J Steroid Biochem Mol Biol 2017;173:139-47. [PMID: 27637326 DOI: 10.1016/j.jsbmb.2016.09.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
71 Campbell MJ. Bioinformatic approaches to interrogating vitamin D receptor signaling. Molecular and Cellular Endocrinology 2017;453:3-13. [DOI: 10.1016/j.mce.2017.03.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
72 Jones G. Vitamin D analogs. Endocrinol Metab Clin North Am 2010;39:447-72, table of contents. [PMID: 20511062 DOI: 10.1016/j.ecl.2010.02.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 2.8] [Reference Citation Analysis]
73 Lee A, Rode A, Nicoll A, Maczurek AE, Lim L, Lim S, Angus P, Kronborg I, Arachchi N, Gorelik A, Liew D, Warner FJ, McCaughan GW, McLennan SV, Shackel NA. Circulating CD147 predicts mortality in advanced hepatocellular carcinoma. J Gastroenterol Hepatol 2016;31:459-66. [PMID: 26312403 DOI: 10.1111/jgh.13148] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
74 El-Sharkawy A, Malki A. Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications. Molecules 2020;25:E3219. [PMID: 32679655 DOI: 10.3390/molecules25143219] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
75 Pendás-Franco N, González-Sancho JM, Suárez Y, Aguilera O, Steinmeyer A, Gamallo C, Berciano MT, Lafarga M, Muñoz A. Vitamin D regulates the phenotype of human breast cancer cells. Differentiation 2007;75:193-207. [PMID: 17288543 DOI: 10.1111/j.1432-0436.2006.00131.x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 77] [Article Influence: 5.7] [Reference Citation Analysis]
76 Holick MF. Vitamin D: Its role in cancer prevention and treatment. Progress in Biophysics and Molecular Biology 2006;92:49-59. [DOI: 10.1016/j.pbiomolbio.2006.02.014] [Cited by in Crossref: 168] [Cited by in F6Publishing: 145] [Article Influence: 10.5] [Reference Citation Analysis]
77 Story MJ. Zinc, ω-3 polyunsaturated fatty acids and vitamin D: An essential combination for prevention and treatment of cancers. Biochimie 2021;181:100-22. [PMID: 33307154 DOI: 10.1016/j.biochi.2020.11.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Salomón DG, Grioli SM, Buschiazzo M, Mascaró E, Vitale C, Radivoy G, Perez M, Fall Y, Mesri EA, Curino AC, Facchinetti MM. Novel alkynylphosphonate analogue of calcitriol with potent antiproliferative effects in cancer cells and lack of calcemic activity. ACS Med Chem Lett 2011;2:503-8. [PMID: 24900339 DOI: 10.1021/ml200034w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
79 Dimitroulopoulos D, Xinopoulos D, Tsamakidis K, Zisimopoulos A, Andriotis E, Panagiotakos D, Fotopoulou A, Chrysohoou C, Bazinis A, Daskalopoulou D. Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial. World J Gastroenterol. 2007;13:3164-3170. [PMID: 17589893 DOI: 10.3748/wjg.v13.i13.3164] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Hoan NX, Tong HV, Song LH, Meyer CG, Velavan TP. Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review. World J Gastroenterol 2018; 24(4): 445-460 [PMID: 29398866 DOI: 10.3748/wjg.v24.i4.445] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
81 Merle P, Mornex F. [Medical therapies for hepatocellular carcinoma]. Cancer Radiother 2011;15:28-31. [PMID: 21237692 DOI: 10.1016/j.canrad.2010.12.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
82 Giammanco M, Di Majo D, La Guardia M, Aiello S, Crescimannno M, Flandina C, Tumminello FM, Leto G. Vitamin D in cancer chemoprevention. Pharm Biol 2015;53:1399-434. [PMID: 25856702 DOI: 10.3109/13880209.2014.988274] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 5.9] [Reference Citation Analysis]
83 Keane JT, Elangovan H, Stokes RA, Gunton JE. Vitamin D and the Liver-Correlation or Cause? Nutrients 2018;10:E496. [PMID: 29659559 DOI: 10.3390/nu10040496] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
84 Krishnan AV, Trump DL, Johnson CS, Feldman D. The role of vitamin D in cancer prevention and treatment. Endocrinol Metab Clin North Am. 2010;39:401-418, table of contents. [PMID: 20511060 DOI: 10.1016/j.ecl.2010.02.011] [Cited by in Crossref: 114] [Cited by in F6Publishing: 96] [Article Influence: 9.5] [Reference Citation Analysis]
85 Ibe K, Yamada T, Okamoto S. Synthesis and vitamin D receptor affinity of 16-oxa vitamin D3 analogues. Org Biomol Chem 2019;17:10188-200. [PMID: 31769776 DOI: 10.1039/c9ob02339a] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
86 Ray R, Lambert JR. 1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action. Bioorg Med Chem Lett 2011;21:2537-40. [PMID: 21392983 DOI: 10.1016/j.bmcl.2011.02.025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
87 Trump DL. Calcitriol and cancer therapy: A missed opportunity. Bone Rep 2018;9:110-9. [PMID: 30591928 DOI: 10.1016/j.bonr.2018.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
88 Khan S, Ali A, Khan S, Bakillah A, Damanhouri G, Khan A, Makki A, AlAnsari I, Banu N. Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D. Nutr Metab (Lond) 2018;15:13. [PMID: 29449867 DOI: 10.1186/s12986-018-0251-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
89 Li Q, Gao Y, Jia Z, Mishra L, Guo K, Li Z, Le X, Wei D, Huang S, Xie K. Dysregulated Krüppel-like factor 4 and vitamin D receptor signaling contribute to progression of hepatocellular carcinoma. Gastroenterology. 2012;143:799-810.e1-e2. [PMID: 22677193 DOI: 10.1053/j.gastro.2012.05.043] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
90 Kang Z, Wang C, Han X, Wang B, Yuan H, Hou S, Hao M, Du J, Li Y, Zhou A, Zhang C. Sulfonyl-containing phenyl-pyrrolyl pentane analogues: Novel non-secosteroidal vitamin D receptor modulators with favorable physicochemical properties, pharmacokinetic properties and anti-tumor activity. European Journal of Medicinal Chemistry 2018;157:1174-91. [DOI: 10.1016/j.ejmech.2018.08.085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
91 Chiang KC, Yeh CN, Chen HY, Lee JM, Juang HH, Chen MF, Takano M, Kittaka A, Chen TC. 19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cells. Steroids. 2011;76:1513-1519. [PMID: 21888924 DOI: 10.1016/j.steroids.2011.08.006] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
92 Cheung FS, Lovicu FJ, Reichardt JK. Current progress in using vitamin D and its analogs for cancer prevention and treatment. Expert Rev Anticancer Ther 2012;12:811-37. [PMID: 22716497 DOI: 10.1586/era.12.53] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
93 Huang YW, Liao YT, Chen W, Chen CL, Hu JT, Liu CJ, Lai MY, Chen PJ, Chen DS, Yang SS, Kao JH. Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan. Genes Immun. 2010;11:87-93. [PMID: 19693091 DOI: 10.1038/gene.2009.65] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
94 Orell-kotikangas H, Schwab U, Österlund P, Saarilahti K, Mäkitie O, Mäkitie AA. High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosis. Head Neck 2012;34:1450-5. [DOI: 10.1002/hed.21954] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
95 Duffy MJ, Murray A, Synnott NC, O'Donovan N, Crown J. Vitamin D analogues: Potential use in cancer treatment. Crit Rev Oncol Hematol 2017;112:190-7. [PMID: 28325259 DOI: 10.1016/j.critrevonc.2017.02.015] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
96 Díaz R, González-Sancho JM, Soldevilla B, Silva J, García JM, García V, Peña C, Herrera M, Gómez I, Bonilla F, Domínguez G. Differential regulation of TP73 isoforms by 1α,25-dihydroxyvitamin D3 and survivin in human colon and breast carcinomas. Genes Chromosomes Cancer 2010;49:1135-42. [PMID: 20842728 DOI: 10.1002/gcc.20821] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
97 Sell S. Stem cell origin of cancer and differentiation therapy. Crit Rev Oncol Hematol. 2004;51:1-28. [PMID: 15207251 DOI: 10.1016/j.critrevonc.2004.04.007] [Cited by in Crossref: 419] [Cited by in F6Publishing: 373] [Article Influence: 24.6] [Reference Citation Analysis]
98 Rao J, Wu X, Zhou X, Deng R, Ma Y. Vitamin D Receptor Fok I Polymorphism and Risk of Hepatocellular Carcinoma in HBV-Infected Patients. Hepat Mon 2019;In Press. [DOI: 10.5812/hepatmon.85075] [Reference Citation Analysis]
99 Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81:353-373. [PMID: 16529140 DOI: 10.4065/81.3.353] [Cited by in Crossref: 1146] [Cited by in F6Publishing: 998] [Article Influence: 71.6] [Reference Citation Analysis]
100 Ness RA, Miller DD, Li W. The role of vitamin D in cancer prevention. Chin J Nat Med 2015;13:481-97. [PMID: 26233839 DOI: 10.1016/S1875-5364(15)30043-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
101 Mullin GE, Dobs A. Vitamin d and its role in cancer and immunity: a prescription for sunlight. Nutr Clin Pract. 2007;22:305-322. [PMID: 17507731 DOI: 10.1177/0115426507022003305] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 3.8] [Reference Citation Analysis]
102 Binderup L, Binderup E, Godtfredsen WO, Kissmeyer A. Development of New Vitamin D Analogs. Vitamin D. Elsevier; 2005. pp. 1489-510. [DOI: 10.1016/b978-012252687-9/50088-7] [Cited by in Crossref: 7] [Article Influence: 0.4] [Reference Citation Analysis]
103 Gutierrez JA, Parikh N, Branch AD. Classical and emerging roles of vitamin D in hepatitis C virus infection. Semin Liver Dis. 2011;31:387-398. [PMID: 22189978 DOI: 10.1055/s-0031-1297927] [Cited by in Crossref: 53] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
104 Pálmer HG, Larriba MJ, García JM, Ordóñez-Morán P, Peña C, Peiró S, Puig I, Rodríguez R, de la Fuente R, Bernad A, Pollán M, Bonilla F, Gamallo C, de Herreros AG, Muñoz A. The transcription factor SNAIL represses vitamin D receptor expression and responsiveness in human colon cancer. Nat Med 2004;10:917-9. [PMID: 15322538 DOI: 10.1038/nm1095] [Cited by in Crossref: 181] [Cited by in F6Publishing: 173] [Article Influence: 10.1] [Reference Citation Analysis]